A detailed history of Israel Englander (Millennium Management LLC) transactions in Codex Dna, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 232,395 shares of DNAY stock, worth $429,930. This represents 0.0% of its overall portfolio holdings.

Number of Shares
232,395
Previous 297,524 21.89%
Holding current value
$429,930
Previous $550,000 22.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
N/A
-65,129 Reduced 21.89%
232,395 $429,000
Q4 2023

Feb 14, 2024

BUY
N/A
45,854 Added 18.22%
297,524 $550,000
Q2 2023

Aug 14, 2023

SELL
N/A
-92,381 Reduced 26.85%
251,670 $465,000
Q1 2023

May 15, 2023

SELL
$1.3 - $2.15 $16,629 - $27,502
-12,792 Reduced 3.58%
344,051 $1.07 Million
Q4 2022

Feb 14, 2023

SELL
$1.12 - $1.69 $9,377 - $14,150
-8,373 Reduced 2.29%
356,843 $446,000
Q3 2022

Nov 14, 2022

SELL
$1.7 - $2.36 $116,290 - $161,438
-68,406 Reduced 15.78%
365,216 $606,000

Others Institutions Holding DNAY

About Codex DNA, Inc.


  • Ticker DNAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 29,518,200
  • Market Cap $54.6M
  • Description
  • Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA...
More about DNAY
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.